|Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer|
IF Tannock, R De Wit, WR Berry, J Horti, A Pluzanska, KN Chi, S Oudard, ...
New England Journal of Medicine 351 (15), 1502-1512, 2004
|Alpha emitter radium-223 and survival in metastatic prostate cancer|
C Parker, S Nilsson, D Heinrich, SI Helle, JM O'Sullivan, SD Fosså, ...
New England Journal of Medicine 369 (3), 213-223, 2013
|Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage …|
ND James, MR Sydes, NW Clarke, MD Mason, DP Dearnaley, MR Spears, ...
The Lancet 387 (10024), 1163-1177, 2016
|Abiraterone for prostate cancer not previously treated with hormone therapy|
ND James, JS de Bono, MR Spears, NW Clarke, MD Mason, ...
New England Journal of Medicine 377 (4), 338-351, 2017
|Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial|
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
|Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial|
CC Parker, ND James, CD Brawley, NW Clarke, AP Hoyle, A Ali, ...
The Lancet 392 (10162), 2353-2366, 2018
|Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer|
ND James, SA Hussain, E Hall, P Jenkins, J Tremlett, C Rawlings, ...
New England Journal of Medicine 366 (16), 1477-1488, 2012
|A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor|
JCC Hu, RS Coffin, CJ Davis, NJ Graham, N Groves, PJ Guest, ...
Clinical cancer research 12 (22), 6737-6747, 2006
|Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind …|
O Sartor, R Coleman, S Nilsson, D Heinrich, SI Helle, JM O'Sullivan, ...
The Lancet Oncology 15 (7), 738-746, 2014
|Survival with newly diagnosed metastatic prostate cancer in the “docetaxel era”: data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019)|
ND James, MR Spears, NW Clarke, DP Dearnaley, JS De Bono, J Gale, ...
European urology 67 (6), 1028-1038, 2015
|Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial|
RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...
Medrxiv, 2021.06. 15.21258542, 2021
|Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of …|
CL Vale, S Burdett, LHM Rydzewska, L Albiges, NW Clarke, D Fisher, ...
The lancet oncology 17 (2), 243-256, 2016
|Required growth facilitators propel axon regeneration across complete spinal cord injury|
MA Anderson, TM O’Shea, JE Burda, Y Ao, SL Barlatey, AM Bernstein, ...
Nature 561 (7723), 396-400, 2018
|Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior …|
CN Sternberg, DP Petrylak, O Sartor, JA Witjes, T Demkow, JM Ferrero, ...
Journal of clinical oncology 27 (32), 5431, 2009
|Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015|
S Gillessen, A Omlin, G Attard, JS De Bono, E Efstathiou, K Fizazi, ...
Annals of Oncology 26 (8), 1589-1604, 2015
|Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review|
G Ploussard, S Daneshmand, JA Efstathiou, HW Herr, ND James, ...
European urology 66 (1), 120-137, 2014
|Addition of docetaxel to hormonal therapy in low-and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial|
NW Clarke, A Ali, FC Ingleby, A Hoyle, CL Amos, G Attard, CD Brawley, ...
Annals of Oncology 30 (12), 1992-2003, 2019
|Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta‐analysis|
SC Hillman, DJ McMullan, G Hall, FS Togneri, N James, EJ Maher, ...
Ultrasound in Obstetrics & Gynecology 41 (6), 610-620, 2013
|Confronting false discoveries in single-cell differential expression|
JW Squair, M Gautier, C Kathe, MA Anderson, ND James, TH Hutson, ...
Nature communications 12 (1), 5692, 2021
|Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol|
MR Sydes, MR Spears, MD Mason, NW Clarke, DP Dearnaley, ...
Annals of Oncology 29 (5), 1235-1248, 2018